139 related articles for article (PubMed ID: 33218683)
1. Dispirotripiperazine-core compounds, their biological activity with a focus on broad antiviral property, and perspectives in drug design (mini-review).
Egorova A; Bogner E; Novoselova E; Zorn KM; Ekins S; Makarov V
Eur J Med Chem; 2021 Feb; 211():113014. PubMed ID: 33218683
[TBL] [Abstract][Full Text] [Related]
2. Identification of individual structural fragments of N,N'-(bis-5-nitropyrimidyl)dispirotripiperazine derivatives for cytotoxicity and antiherpetic activity allows the prediction of new highly active compounds.
Artemenko AG; Muratov EN; Kuz'min VE; Kovdienko NA; Hromov AI; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
J Antimicrob Chemother; 2007 Jul; 60(1):68-77. PubMed ID: 17550890
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, cytotoxicity and antiviral activity of N,N'-bis-5-nitropyrimidyl derivatives of dispirotripiperazine.
Schmidtke M; Riabova O; Dahse HM; Stelzner A; Makarov V
Antiviral Res; 2002 Jul; 55(1):117-27. PubMed ID: 12076756
[TBL] [Abstract][Full Text] [Related]
4. Binding of a N,N'-bisheteryl derivative of dispirotripiperazine to heparan sulfate residues on the cell surface specifically prevents infection of viruses from different families.
Schmidtke M; Karger A; Meerbach A; Egerer R; Stelzner A; Makarov V
Virology; 2003 Jun; 311(1):134-43. PubMed ID: 12832211
[TBL] [Abstract][Full Text] [Related]
5. Microbial subversion of heparan sulfate proteoglycans.
Chen Y; Götte M; Liu J; Park PW
Mol Cells; 2008 Nov; 26(5):415-26. PubMed ID: 18799929
[TBL] [Abstract][Full Text] [Related]
6. Spirocyclic nucleosides in medicinal chemistry: an overview.
Soengas RG; Silva S
Mini Rev Med Chem; 2012 Dec; 12(14):1485-96. PubMed ID: 22827180
[TBL] [Abstract][Full Text] [Related]
7. Multivalent Flexible Nanogels Exhibit Broad-Spectrum Antiviral Activity by Blocking Virus Entry.
Dey P; Bergmann T; Cuellar-Camacho JL; Ehrmann S; Chowdhury MS; Zhang M; Dahmani I; Haag R; Azab W
ACS Nano; 2018 Jul; 12(7):6429-6442. PubMed ID: 29894156
[TBL] [Abstract][Full Text] [Related]
8. The Interferon-Inducible Proteoglycan Testican-2/SPOCK2 Functions as a Protective Barrier against Virus Infection of Lung Epithelial Cells.
Ahn N; Kim WJ; Kim N; Park HW; Lee SW; Yoo JY
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341044
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus.
Selinka HC; Florin L; Patel HD; Freitag K; Schmidtke M; Makarov VA; Sapp M
J Virol; 2007 Oct; 81(20):10970-80. PubMed ID: 17686860
[TBL] [Abstract][Full Text] [Related]
10. Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?
Cagno V; Tseligka ED; Jones ST; Tapparel C
Viruses; 2019 Jul; 11(7):. PubMed ID: 31266258
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues.
Klimyte EM; Smith SE; Oreste P; Lembo D; Dutch RE
J Virol; 2016 Oct; 90(20):9237-50. PubMed ID: 27489270
[TBL] [Abstract][Full Text] [Related]
12. (+)- and (-)-Pestaloxazine A, a Pair of Antiviral Enantiomeric Alkaloid Dimers with a Symmetric Spiro[oxazinane-piperazinedione] Skeleton from Pestalotiopsis sp.
Jia YL; Wei MY; Chen HY; Guan FF; Wang CY; Shao CL
Org Lett; 2015 Sep; 17(17):4216-9. PubMed ID: 26291636
[TBL] [Abstract][Full Text] [Related]
13. Antivirals against animal viruses.
Villa TG; Feijoo-Siota L; Rama JLR; Ageitos JM
Biochem Pharmacol; 2017 Jun; 133():97-116. PubMed ID: 27697545
[TBL] [Abstract][Full Text] [Related]
14. [Viral entry as therapeutic target. Current situation of entry inhibitors].
Arenzana-Seisdedos F
Enferm Infecc Microbiol Clin; 2008 Oct; 26 Suppl 11():5-11. PubMed ID: 19133215
[TBL] [Abstract][Full Text] [Related]
15. Heparan Sulfate Proteoglycan Is an Important Attachment Factor for Cell Entry of Akabane and Schmallenberg Viruses.
Murakami S; Takenaka-Uema A; Kobayashi T; Kato K; Shimojima M; Palmarini M; Horimoto T
J Virol; 2017 Aug; 91(15):. PubMed ID: 28539443
[No Abstract] [Full Text] [Related]
16. Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR).
Francesconi V; Giovannini L; Santucci M; Cichero E; Costi MP; Naesens L; Giordanetto F; Tonelli M
Eur J Med Chem; 2018 Jul; 155():229-243. PubMed ID: 29886325
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate-dependent enhancement of henipavirus infection.
Mathieu C; Dhondt KP; Châlons M; Mély S; Raoul H; Negre D; Cosset FL; Gerlier D; Vivès RR; Horvat B
mBio; 2015 Mar; 6(2):e02427. PubMed ID: 25759505
[TBL] [Abstract][Full Text] [Related]
18. Advances in Spirocyclic Hybrids: Chemistry and Medicinal Actions.
Benabdallah M; Talhi O; Nouali F; Choukchou-Braham N; Bachari K; Silva AMS
Curr Med Chem; 2018; 25(31):3748-3767. PubMed ID: 29521213
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia viruses.
Langland J; Jacobs B; Wagner CE; Ruiz G; Cahill TM
Antiviral Res; 2018 Dec; 160():143-150. PubMed ID: 30393014
[TBL] [Abstract][Full Text] [Related]
20. A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.
Krepstakies M; Lucifora J; Nagel CH; Zeisel MB; Holstermann B; Hohenberg H; Kowalski I; Gutsmann T; Baumert TF; Brandenburg K; Hauber J; Protzer U
J Infect Dis; 2012 Jun; 205(11):1654-64. PubMed ID: 22457281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
